Contained Mycobacterium tuberculosis infection induces concomitant and heterologous protection.
Progress in tuberculosis vaccine development is hampered by an incomplete understanding of the immune mechanisms that protect against infection with Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis. Although the M72/ASOE1 trial yielded encouraging results (54% efficacy in subjec...
Guardado en:
Autores principales: | Johannes Nemeth, Gregory S Olson, Alissa C Rothchild, Ana N Jahn, Dat Mai, Fergal J Duffy, Jared L Delahaye, Sanjay Srivatsan, Courtney R Plumlee, Kevin B Urdahl, Elizabeth S Gold, Alan Aderem, Alan H Diercks |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b125e515468469890da614482c96ca1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Heterologous immune responses in health and disease
por: A. P. Toptygina
Publicado: (2020) -
CONCOMITANT LATENT POLYCYTHEMIA VERA AND MGUS.
por: Fidan KHALILOVA, et al.
Publicado: (2021) -
Heterologous Expression of Syntaxin 6 in Saccharomyces cerevisiae
por: GÖTTE,MARTIN, et al.
Publicado: (2002) -
Mycobacterium tuberculosis modifies cell wall carbohydrates during biofilm growth with a concomitant reduction in complement activation
por: Thomas Keating, et al.
Publicado: (2021) -
Biochemical mechanisms determine the functional compatibility of heterologous genes
por: Andreas Porse, et al.
Publicado: (2018)